SG Americas Securities, LLC - JOUNCE THERAPEUTICS INC ownership

JOUNCE THERAPEUTICS INC's ticker is JNCE and the CUSIP is 481116101. A total of 85 filers reported holding JOUNCE THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.75 and the average weighting 0.0%.

Quarter-by-quarter ownership
SG Americas Securities, LLC ownership history of JOUNCE THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$28
+86.7%
15,195
+11.4%
0.00%
Q4 2022$15
-100.0%
13,635
+1.0%
0.00%
Q3 2022$32,000
-33.3%
13,495
-14.4%
0.00%
-100.0%
Q2 2022$48,000
-72.4%
15,768
-32.6%
0.00%0.0%
Q3 2021$174,000
+216.4%
23,393
+44.3%
0.00%
Q4 2018$55,000
-81.3%
16,213
-29.7%
0.00%
-100.0%
Q4 2017$294,00023,0790.00%
Other shareholders
JOUNCE THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
TRV GP II, LLC 2,697,829$20,045,00088.84%
TRV GP III, LLC 3,048,780$22,652,0004.30%
Logos Global Management LP 2,000,000$14,860,0001.07%
SILVERARC CAPITAL MANAGEMENT, LLC 208,559$1,550,0000.88%
PFM Health Sciences, LP 3,848,822$28,597,0000.84%
Yorktown Management & Research Co Inc 113,200$841,0000.63%
Moloney Securities Asset Management, LLC 282,250$2,097,0000.38%
PATHWAY CAPITAL MANAGEMENT, LP 84,763$630,0000.30%
Sofinnova Investments, Inc. 637,347$4,735,0000.28%
Omega Fund Management, LLC 275,513$2,047,0000.23%
View complete list of JOUNCE THERAPEUTICS INC shareholders